Intramuscular depot medroxyprogesterone acetate accentuates bone loss associated with tenofovir disoproxil fumarate-containing antiretroviral therapy initiation in young women living with HIV (the BONE: CARE study): a prospective cohort study in Uganda

BACKGROUND: Tenofovir disoproxil fumarate (TDF) and intramuscular depot medroxyprogesterone acetate (DMPA-IM) are independently associated with reduced bone mineral density (BMD). We aimed to assess the combined effects of DMPA-IM use and TDF initiation on BMD in young adult women living with HIV ov...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiweewa Matovu, Flavia, Kiwanuka, Noah, Nabwana, Martin, Scholes, Delia, Musoke, Philippa, Glenn Fowler, Mary, Beksinska, Mags E, Pettifor, John M, Brown, Todd T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449816/
https://www.ncbi.nlm.nih.gov/pubmed/35427526
http://dx.doi.org/10.1016/S2214-109X(22)00080-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449816/
https://www.ncbi.nlm.nih.gov/pubmed/35427526
http://dx.doi.org/10.1016/S2214-109X(22)00080-8

Ejemplares similares